Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-062612

Chief Financial Officer sold 30,000 shares at an average $51.24 ($1,537,238)

  • Chief Financial Officer acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-08 Exercise or conversion : show line 1 in the form +30,000 $6.32 $189,600 31,000 D
2020-12-08 Sale : show line 2 in the form −20,256 $50.88 $1,030,625 10,744 D
2020-12-08 Sale : show line 3 in the form −9,444 $51.98 $490,899 1,300 D
2020-12-08 Sale : show line 4 in the form −300 $52.38 $15,714 1,000 D
Open-market sales · 30,000 sh · avg $51.24 · $1,537,238

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-08 Exercise or conversion : show line 5 in the form Stock Option (Right To Buy) −30,000 490,000 D
Loading xslF345X03/doc4.xml…